From March 28 to March 29, 2024, the fifth (2024) China·Harbin Pig Industry Summit was held grandly, focusing on "discussing experience, improving quality and efficiency, maintaining stability and mutual benefit, and strengthening the industry". The content of "trend analysis, breeding development, epidemic prevention and control, and management methods" was developed as the theme of the conference, and future industry development and response plans were elaborated. This event brings together industry leaders and pig farm customers from all over the country to participate in this event.

Expert interviews

The fifth (2024) China·Harbin Pig Industry Summit brings together industry leaders, coordinates multiple resources, focuses on how to improve performance, achieve increased corporate benefits, and discuss the risks and risks faced by the current pig industry. We conducted in-depth exchanges of experiences and jointly discussed the development path of China's pig industry.

Harbin Lvda Animal Pharmaceuticals has always adhered to the corporate mission of "leading green breeding and serving human health", strongly supported the convening of the Pig Industry Summit, and assisted the progress and development of the industry.

In recent years, China's pig industry has experienced a difficult period of industry-wide losses and difficulties in upstream and downstream operations, and is facing unprecedented challenges; group pig farming has developed rapidly, large-scale pig farms, family farms, and small and medium-sized pig enterprises have begun to decrease, and the number of free-range pig farmers has increased. is a sharp decline, and the industrial structure is gradually changing. At this critical moment when opportunities and challenges coexist, we need to gather industry wisdom and jointly explore ways to develop in the future. Lvda Biopharmaceutical Industry is willing to work together with people in the industry to seek development and overcome difficulties.